Oncology and Hematology Clinical Practice Guidelines - 2022 Midyear Review

2022 clinical practice guideline update on non–small cell lung cancer from the National Comprehensive Cancer Network (NCCN), published in the Journal of the National Comprehensive Cancer Network.

2022 guidelines for management of progressive glioblastoma from the Congress of Neurological Surgeons (CNS)

2022 guidelines for management of soft-tissue tumors from the Japanese Orthopaedic Association (JOA)

2022 guidelines from the National Comprehensive Cancer Network for the management of Hodgkin lymphoma, published in Journal of the National Comprehensive Cancer Network

2022 clinical practice guidelines on bone sarcoma from the Sarcoma European Latin-American Network (SELNET), published in Critical Reviews in Oncology/Hematology

2022 clinical practice guideline on endometrial cancer from the Spanish Society of Medical Oncology/Spanish Group for Investigation in Ovarian Cancer, published in Clinical and Translational Oncology.

2022 clinical practice guideline update on colon cancer from the American Society of Colon and Rectal Surgeons (ASCRS), published in Diseases of the Colon & Rectum.

2022 guidelines on hepatocellular carcinoma from the American Gastroenterological Association, published in Gastroenterology.

2022 guidelines for management of malignant pleural mesothelioma (MPM) from the European Society for Medical Oncology (ESMO), published in Annals of Oncology

2022 clinical practice guideline update on Waldenstrom macroglobulinemia from the British Society for Haematology (BSH), published in the British Journal of Haematology.